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The SP-4 culture medium, developed originally for newly isolated plant and insect
mycoplasmas (spiroplasmas), has markedly improved the recovery of Mycoplasma pneumo-
niae from human clinical materials. This medium, in combination with a direct fluorescent an-
tibody test, can enhance the recovery and identification ofthe organism by 30-40 percent over
conventional culture procedures. Although these modifications are a clear improvement in
diagnostic techniques for M. pneumoniae, the time required for growth and identification of
the agent is still a major disadvantage for rapid clinical diagnosis. Thus, there remains a critical
need for techniques that can specifically identify the major antigens (or other components) of
the organism within the first week of the infection.
INTRODUCTION
The laboratory diagnosis of Mycoplasma pneumoniae infections is an important
and necessary adjunct to clinical impressions in establishing the role of the agent in
acute human respiratory disease. In addition, clinical experiences reported over the
past ten years have emphasized the involvement ofthis organism in a wide spectrum
of other pulmonary manifestations and in some important and serious ex-
trapulmonary syndromes [1]. In these latter situations, the association with M.
pneumoniae may occur with, or in the absence of, overt respiratory disease symp-
toms. Thus, it is important that both clinical and laboratory personnel encourage
performance ofproper laboratory diagnostic techniques for this organism on all pa-
tients in early stages of respiratory disease and in those individuals with symptoms
known to be associated with extrapulmonary M. pneumoniae infections (e.g., peri-
carditis, hemolytic anemia, encephalitis, and so on). Adequate and early diagnosis
ofM. pneumoniae infections also has important clinical significance, since effective
antibiotic therapy is available in the form of tetracycline or erythromycin drugs.
The laboratory diagnosis ofM. pneumoniae infections rests primarily on an ade-
quate serological analysis ofthe patient's serum (which is discussed elsewhere in this
symposium) and on the isolation and identification ofthe organism from secretions
of the respiratory tract or other appropriate sites [2,3].
Few technical improvements in cultivation techniques have been proposed for this
organism since the initial discovery of the agent [4]. The basic mycoplasma medium
employed for most work has centered around a formulation developed by Derrick
Edward [5], consisting of a base medium of seven parts beefheart infusion and sup-
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plements of two parts sterile horse serum, one part fresh yeast extract, glucose (0.5
percent final), and phenol red indicator (0.002 percent final) [4]. Broth cultures
showing a decline in pH (from glucose fermentation) or increased turbidity are
plated to a solid medium (of the above formulation, but excluding glucose and
phenol red). Agar colonies ofM. pneumoniae are identified on the basis of hemad-
sorption [6], hemolysis [7], or by a plate immunofluorescence test with specific M.
pneumoniae antiserum [8].
MATERIALS AND METHODS
Culture Medium
The formulation of the SP-4 medium is given in Table 1. A diphasic medium is
prepared in 4 ml vials by placing 1 ml of melted SP-4 agar medium (prepared with
0.8 percent Noble agar) in the bottom of a sterile vial. The agar is allowed to solidify
and 2 ml of SP-4 broth is overlaid on to the agar. Broth medium for throat cultures
should contain penicillin G (final 1,000 units/ml) and thallium acetate (final 0.5
mg/ml). For some throat specimens with heavy bacterial loads (such as in pediatric
patients), thallium levels should be increased (to final 1 mg/ml) and polymyxin B
(final 500 units/ml) added to the broth overlay. Mycoplasma agar plates are
prepared from either the SP-4 formula or from conventional mycoplasma broth
containing 20 percent horse serum. It is important to use only washed or purified
agar (Noble, agarose) and bacterial inhibitors (thallium acetate, penicillin G) in any
solid medium.
Quality control of medium components is a critical factor in cultivation of the
organism, since unsatisfactory lots of base medium, fresh yeast extract, or fetal
bovine serum are encountered (see [2] or [9] for detailed procedures).
Specimen Collection and Transport
Throat and nasopharyngeal swabs, tissues from lung orbrain, and spinal, pleural,
or pericardial fluids should be placed immediately in diphasic SP-4 medium and
TABLE I
SP-4 medium for recovery of Mycoplasma pneumoniae
Basal Medium Amounts for 1 liter
Mycoplasma Broth Base 3.5 g
Bacto Peptone 5.3 g
Bacto Tryptone 10.0 g
Glucose 5.0 g
De-ionized water 560 ml
Adjust pH to 7.5-7.6. Sterilize at 121°C for 15 minutes.
Sterile supplements Amounts for 1 liter
CMRL 1066 tissue culture supplement-
(10x) (with glutamine) 50 ml
Fresh yeast extract (25% solution) 35 ml
Yeastolate (2% solution) (Difco) 100 ml
Fetal bovine serum (heated 56°C-I hour) 170 ml
Penicillin G (100,000 units/ml) 10 ml
Thallium acetate (1:50 solution) 50 ml
Polymyxin B (100,000 units/ml) (optional) 5 ml
Phenol red (0.1% aqueous) 20 ml
Final pH, 7.4-7.5 Osmolality, 332 mOm
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onto solid mycoplasma media [5], or into a suitable transport medium (such as con-
ventional mycoplasma broth containing 20 percent horse serum) (Fig. 1). If the
specimen cannot be cultured within 24 hours of collection, it should be frozen (in
transport medium) at -70°C until appropriate materials are available.
Cultivation Procedures
A recommended scheme for cultivation ofM. pneumoniaeis given in Fig. 1. After
addition of 0.1 to 0.2 ml of the transport specimen to SP-4 diphasic medium, the
transport specimen should be refrozen at -70°C in case repeat tests are required.
Tissues should be minced coarsely and then added to about 5 ml of SP-4 broth. At
least two tenfold dilutions of the initial suspension should be made in SP-4 broth to
reduce possible inhibitory substances from tissues (antibiotics, antibodies,
hemoglobin, lysolecithin, and so on). During incubation, the SP-4 diphasic vials
should be observed every 3-5 days for decreases in the pH indicator or for increased
turbidity in the broth phase. When this occurs, small volumes (0.1 to 0.2 ml) are
plated to conventional mycoplasma agar plates and subcultures made to fresh SP-4
diphasic medium. Plates are incubated (37°C) aerobically (but sealed to prevent
dehydration), or are placed in an environment of 95 percent nitrogen-5 percent car-
bon dioxide. Mycoplasma colonies usually appear after incubation periods of 5-14
days.
Identification ofIsolates
The most rapid and specific identification ofM. pneumoniaecolonies growing on
agar plates is accomplished through a direct plate immunofluorescence antibody test
/-00[8]. The plates are flooded with about 1-2 ml ofphosphate-buffered saline and then
allowed to soak for 20-30 minutes at room temperature. The wash fluid is discarded
in a beaker (for eventual disinfection) and about 1 ml ofan appropriate dilution ofa
fluorescein-conjugated antiserum specific for M. pneumoniae is added to the plate.
The dilution of conjugate selected will depend upon the potency of the antiserum,
but a conjugate dilution of 1:20 to 1:40 will usually provide strong fluorescence of
M. pneumoniae colonies. After a 20- to 30-minute incubation of agar colonies and
conjugate, the conjugate is poured off (in beaker for disinfection) and the plates
again washed two or three times with about 2-3 ml of saline. After final wash, the
plates are inverted and dried for 20 minutes. The plates are examined with a
fluorescence microscope equipped with incident illumination. Colonies are scanned
under magnification of about x 160, using incandescent light for transmitted il-
lumination and aquartz-halogen or high-pressure mercury vapor lamp source for in-
cident illumination. Recommended filter systems include the following: BP
450/490, FT 510, and LP 520, for exciter, beam splitter, and barrier filters, respec-
tively.
Confirmation ofM. pneumoniae colonies on agar can be accomplished by prepar-
ing duplicate plates of the throat culture specimen and selecting colonies of the size
and shape of those staining with specific conjugate. These colonies are then trans-
ferred to fresh broth or agar and the resulting growth eventually obtained on agar
plates identified by conventional growth inhibition tests [10]. Conversely, duplicate
agar plates of the primary culture can be flooded with a suspension of 5 percent
guinea pig erythrocytes in saline, and the colonies examined microscopically for ad-
sorption of erythrocytes to specific colonies [6], or an overlay of guinea pig
erythrocytes in agar added to the plate and plates re-incubated for observations on
the development of hemolytic zones around M. pneumoniae colonies [7].
RESULTS AND DISCUSSION
The SP-4 medium formulation was initially developed for the growth of helical
mycoplasmas [11]. The value of the medium to support the growth of M.
pneumoniae from human throat culture specimens was shown in a study [12] where
SP-4 medium was compared to recovery rates of the organism in the standard
mycoplasma medium containing 20 percent horse serum. An increased isolation rate
of 30-40 percent was found with SP-4 medium. In addition, that study also in-
dicated that the incorporation of methylene blue [13], at least when added to SP-4
medium, significantly inhibited the growth of M. pneumoniae.
In those individuals who are shedding significant amounts of the organism (such
as in acute respiratory disease or early convalescence), the diphasic medium will
show changes in pH indicator (to yellow) within 8-15 days. When these SP-4 broth
cultures are transferred to agar plates, a pure culture of the organism is usually ap-
parent by immunofluorescent tests. In those individuals in late convalescence phases
of M. pneumoniae infection (or even in some asymptomatic individuals), few M.
pneumoniae colonies may be apparent on agar plates stained with specific con-
jugates. Frequently, these colonies may be mixed with colonies of other mycoplas-
mas common to the normal flora of the mouth or throat (M. orale and M.
salivarium). In these situations, it is important to examine the plate carefully by the
fluorescent technique to search out the one or two M. pneumoniae colonies that
might be present.
Finally, we have frequently observed an alkaline shift in the SP-4 broth,
presumably due to the growth of such arginine-hydrolyzing mycoplasmas as M.
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orale or M. salivarium. When these broth cultures were plated to agar and resulting
colonies examined by fluorescence with M. pneumoniae conjugates, as much as 50
percent ofthe colony population was found to be M. pneumoniae. We believe this is
perhaps the result of more vigorous metabolism of arginine-hydrolyzing mycoplas-
mas in competition with glucose-fermenting M. pneumoniae. This observation sug-
gests that when any change occurs in the indicator of the SP-4 broth, either to the
acid or alkaline side, appropriate platings of the culture to solid media should be
done as soon as possible.
The modifications described here generally enhance the recovery of M.
pneumoniae and provide laboratory confirmation of the role of the organism in in-
fection. However, even in the best of circumstances, growth of the organism in liq-
uid medium, then growth on the agar medium, and final identification by direct im-
munofluorescent antibody test may require 2-3 weeks. This is not an ideal situation,
particularly from a clinical standpoint when decisions on appropriate therapy may
rest on more adequate information as to the nature of the etiologic agent. Thus,
there is still a critical need for a rapid diagnostic test that will specifically identify the
major antigens (or other important components) associated with this organism.
Logically, this test should be performed on sputum or throat washings at an early
stage of the infection and when the patient is shedding the largest numbers of M.
pneumoniae. The recent identification of M. pneumoniae proteins associated with
hemadsorption and cytadsorption (such as the P1 protein) [14-16] might eventually
offer a suitable detection system for rapid diagnosis of M. pneumoniae infections.
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